Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023
05 oct. 2023 16h30 HE
|
Vir Biotechnology, Inc.
Vir Biotechnology will provide a corporate update and report financial results for the third quarter ended September 30, 2023, on November 2, 2023.
Codere Online Reports Financial Results for the Third Quarter of 2022
16 nov. 2022 07h30 HE
|
Codere Online Luxembourg, S.A.
Total revenue was €28.9 mm in Q3 2022 (51% above Q3 2021), while net gaming revenue was €30.6 mm in the period (54% above Q3 2021)1.Mexico revenue was €11.4 mm in Q3 2022 (80% above Q3 2021), while...
Exagen Inc. Reports Third Quarter 2022 Results
14 nov. 2022 16h05 HE
|
Exagen Inc.
SAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2022....
Onex Reports Third Quarter 2022 Results and Provides Leadership Transition Update
11 nov. 2022 07h00 HE
|
ONEX Corporation
All amounts in U.S. dollars unless otherwise stated TORONTO, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Onex Corporation (TSX: ONEX) today announced its financial results for the third quarter and nine...
VitalHub Reports Q3 2022 Financial Results with Record Revenue of $9.8M and Adjusted EBITDA of $2.2M
10 nov. 2022 19h41 HE
|
Vitalhub Corp.
TORONTO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX:VHI) (OTCQX:VHIBF) announced today it has filed its Interim Condensed Consolidated Financial Statements...
Entera Bio Provides Corporate Updates and Financial Results for the Third Quarter of 2022
10 nov. 2022 16h15 HE
|
Entera Bio Ltd.
JERUSALEM, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
GXO Logistics Reports Third Quarter 2022 Results
08 nov. 2022 16h30 HE
|
GXO Logistics
Highlights Third quarter revenue of $2.3 billion, up 16% year-over-year; including organic revenue growth1 of 16%; net income attributable to GXO of $63 million; adjusted EBITDA1 of $192 million;...
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
03 nov. 2022 16h03 HE
|
Vir Biotechnology, Inc.
- Biomedical Advanced Research and Development Authority (BARDA) awarded contract to support pandemic preparedness for influenza and other infectious diseases; initial investment of ~$55.0 million...
Bombardier présente de solides résultats pour le troisième trimestre de 2022 appuyés par de robustes données fondamentales, accroît ses liquidités au moyen d’une facilité de crédit rotative garantie, et poursuit son désendettement accéléré, grâce à un remboursement de 100 millions $ de sa dette
03 nov. 2022 06h30 HE
|
Bombardier Inc.
Solides revenus de 1,5 milliard $ pour le troisième trimestre, incluant des revenus tirés des activités de service après-vente de 372 millions $ qui ont augmenté de 20 % par rapport à ceux de la...
Bombardier Reports Strong Third Quarter 2022 Results with Solid Fundamentals, Grows Liquidity with Secured Revolver Facility, and Continues Accelerated Deleveraging with $100 Million Debt Paydown
03 nov. 2022 06h30 HE
|
Bombardier Inc.
Solid third quarter revenues of $1.5 billion include a 20% year-over-year aftermarket increase to $372 million; full-year deliveries on track for more than 120 aircraft(1). Adjusted EBITDA(2) for the...